EUK-134 | m-entrepreneurship.com

Product Name :
EUK-134

Search keywords :
EUK-134

drugId :
null

Target Vo:
Free radicals

Target Vo Short Name :
Free radicals

Moa_Name:
Free radicals scavengers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eukarion Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Epilepsy

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alirocumab Metabolic Enzyme/Protease
CD3D Rabbit mAb Description
SOCS1 Antibody: SOCS1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to SOCS1. It can be used for ICC/IF,WB,IHC-F,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts